Kolexia
Amiot Aurelien Gastro-entérologie
Amiot Aurelien
Gastro-entérologie
Hôpital Henri Mondor
Créteil, France
265 Activités
5 Followers
Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Maladies inflammatoires intestinales Maladie de Crohn Rectocolite hémorragique Colite Nécrose Lymphomes Lymphome B de la zone marginale Tumeurs colorectales Urgences

Collaborateurs

Voir plus
Peyrin-Biroulet Laurent
Peyrin-Biroulet Laurent
Hôpital Brabois, Vandoeuvre-lès-Nancy, France
Laharie David
Laharie David
Hôpital Haut-lévêque, Pessac, France
Bouhnik Yoram
Bouhnik Yoram
Cmc Ambroise Pare Hartmann Site 25, Neuilly-sur-Seine, France
Fumery Mathurin
Fumery Mathurin
Centre Hospitalier D'Amiens Salouël Site Sud, Salouël, France

Industries

Voir plus
Janssen
30 collaboration(s)
Dernière en 2023
Abbvie
29 collaboration(s)
Dernière en 2023
Takeda Pharmaceutical
28 collaboration(s)
Dernière en 2023
Biogen
13 collaboration(s)
Dernière en 2023

Dernières activités

Voir plus
Effectiveness and safety of a third-line rescue treatment for acute severe ulcerative colitis refractory to infliximab or ciclosporin (REASUC study).
Alimentary pharmacology & therapeutics   06 mars 2024
RCH et colite aiguë grave : avantage à une combothérapie d’emblée chez les répondeurs aux CTC i.v. ?
Edimark   24 février 2024
Rates of adverse events in patients with ulcerative colitis undergoing colectomy during treatment with tofacitinib vs biologics: a multicenter observational study.
The American journal of gastroenterology   02 février 2024
Infliximab is an effective option in patients with ulcerative colitis previously exposed to full subcutaneous anti-TNF agent: Results from a real-world multicenter study.
Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver   27 janvier 2024
Dietary index based on the Food Standards Agency nutrient profiling system and risk of Crohn's disease and ulcerative colitis.
Alimentary pharmacology & therapeutics   15 décembre 2023
ABTECT - Maintenance: A Randomized, Double-blind, Multicenter Phase III Study to Evaluate the Long-term Efficacy and Safety of ABX464 25 mg or 50 mg Once Daily as a Maintenance Therapy in Subjects With Moderately to Severely Active Ulcerative Colitis
Essai Clinique (Abivax S.A.)   15 décembre 2023
ABTECT-1 - ABX464 Treatment Evaluation for Ulcerative Colitis Therapy -1: A Randomized, Double-blind, Placebo-controlled, Multicenter Phase III Study to Evaluate the Efficacy and Safety of ABX464 Once Daily for Induction Treatment in Subjects With Moderately to Severely Active Ulcerative Colitis
Essai Clinique (Abivax S.A.)   15 décembre 2023
Gastric microbiota in patients with gastric MALT lymphoma according to Helicobacter pylori infection.
Clinics and research in hepatology and gastroenterology   18 novembre 2023
Prevalence and Determinants of Fatigue in Patients with IBD: A Cross-Sectional Survey from the GETAID.
Journal of Crohn's & colitis   20 octobre 2023
Lymphoma In Patients With Inflammatory Bowel Disease: A Multicenter Collaborative Study Between Getaid And Lysa.
Journal of Crohn's & colitis   18 octobre 2023